MetLife Investment Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,151
| Closed | -$89.7K | – | 2902 |
|
|
2024
Q1 | $89.7K | Buy |
21,151
+350
| +2% | +$1.48K | ﹤0.01% | 2583 |
|
|
2023
Q4 | $111K | Hold |
20,801
| – | – | ﹤0.01% | 2558 |
|
|
2023
Q3 | $89.4K | Hold |
20,801
| – | – | ﹤0.01% | 2627 |
|
|
2023
Q2 | $114K | Buy |
+20,801
| New | +$114K | ﹤0.01% | 2595 |
|
|
2022
Q2 | – | Sell |
-16,835
| Closed | -$105K | – | 2879 |
|
|
2022
Q1 | $105K | Buy |
16,835
+2,010
| +14% | +$12.5K | ﹤0.01% | 2614 |
|
|
2021
Q4 | $105K | Hold |
14,825
| – | – | ﹤0.01% | 2393 |
|
|
2021
Q3 | $103K | Buy |
+14,825
| New | +$103K | ﹤0.01% | 2429 |
|